A novel Met-to-Thr mutation in the YMDD motif of reverse transcriptase from feline immunodeficiency virus confers resistance to oxathiolane nucleosides. [electronic resource]
- Journal of virology Mar 1997
- 2357-62 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0022-538X
10.1128/JVI.71.3.2357-2362.1997 doi
Animals Antiviral Agents--pharmacology Binding Sites Cats Cell Line Drug Resistance, Microbial--genetics Emtricitabine--analogs & derivatives Immunodeficiency Virus, Feline--drug effects Lamivudine--pharmacology Methionine Mutagenesis, Site-Directed RNA-Directed DNA Polymerase--genetics Sequence Analysis, DNA Threonine Viral Plaque Assay Zalcitabine--analogs & derivatives